Company intelligence / Profile preview
Institut Mérieux
Lyon, Franceinstitut-merieux.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Institut Mérieux is a global life sciences holding company specializing in diagnostics, immunotherapy, public health, and nutrition, with major subsidiaries including bioMérieux (diagnostics), Transgene (cancer/infectious disease immunotherapy), and Mérieux NutriSciences (food safety and nutrition). Subsidiary pipeline stages range from preclinical to commercial, particularly in cancer immunotherapies and infectious disease solutions.
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- VaccineImmunotherapyDiagnosticsGene therapyMonoclonal antibodySmall moleculeBiologic
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
Sanofi Pasteur (historical, via vaccine legacy)Various biotech/health/academia institutions worldwide
Beyond the preview
Go deeper on Institut Mérieux.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Institut Mérieux.